1.
Response Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
2.
Cervical cancer screening in the United States and the Netherlands: A tale of two countries
The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening